CoChat

Extracellular TDP‐43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase‐3/IL‐18 signaling in microglia

Leal‐Lasarte, María M., Franco, Jaime M., Labrador‐Garrido, Adahir, Pozo, David, Roodveldt, Cintia · 2017 · The FASEB Journal
Cited by 53

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Dysregulated microglial responses are central in neurodegenerative proteinopathies, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar disease (FTLD). Pathologic TDP‐43, which is typically found in intracellular inclusions, is a misfolding protein with emerging roles in ALS and FTLD. Recently, TDP‐43 species have been found in extracellular fluids of patients; however, the overall implications of TDP‐43–mediated signaling linked to neuroinflammation are poorly understood. Our work—the first, to our knowledge, to focus on innate immunity responses to TDP‐43 aggregates—shows that such species are internalized by microglia and cause abnormal mobilization of endogenous TDP‐43. Exposure to TDP‐43 aggregates elicited not only IL‐1β, but also NLRP3dependent and noncanonical IL‐18 processing. Moreover, we report a link between TDP‐43 and neuronal loss via the apoptosis‐independent emerging roles of caspase‐3 in neurotoxic inflammation. Our results further support the view of noncell autonomous neurodegenerative mechanisms in ALS. Remarkably, we demonstrate that TDP‐43 aggregates bind to and colocalize with MAPK/MAK/MRK overlapping kinase (MOK) and show that its phosphorylation status is disrupted. Finally, we show that this TDP‐43–caused activation state can be altered by exogenous Hsp27 and Hsp70 chaperones. Our study provides new insight into the immune phenotype, mechanisms, and signaling pathways that operate in microglial neurotoxic activation in ALS.—Leal‐Lasarte, M. M., Franco, J. M., Labrador‐Garrido, A., Pozo, D., Roodveldt, C. Extracellular TDP‐43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase‐3/IL‐18 signaling in microglia. FASEB J. 31, 2797–2816 (2017). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.201601163r

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 54

  1. Hardiman O., 2011, Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat. Rev, Neurol., 7, 639
  2. 10.1007/s13311-014-0329-3 · DOI · Paper page
  3. 10.3389/fncel.2015.00414 · DOI · Paper page
  4. 10.1126/science.1134108 · DOI · Paper page
  5. Arai T., 2006, TDP‐43 is a component of ubiquitin‐positive tau‐negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res, Commun., 351, 602
  6. Mackenzie I. R., 2007, Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann, Neurol., 61, 427
  7. 10.1111/j.1440-1789.2009.01029.x · DOI · Paper page
  8. 10.1007/s00401-008-0477-9 · DOI · Paper page
  9. 10.1111/j.1742-4658.2011.08256.x · DOI · Paper page
  10. Steinacker P., 2008, TDP‐43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch, Neurol., 65, 1481
  11. 10.3109/17482968.2010.541263 · DOI · Paper page
  12. 10.18632/oncotarget.4680 · DOI · Paper page
  13. 10.1016/j.celrep.2013.06.007 · DOI · Paper page
  14. Smethurst P., 2015, Review: prion‐like mechanisms of transactive response DNA binding protein of 43 kDa (TDP‐43) in amyotrophic lateral sclerosis (ALS). Neuropathol. Appl, Neurobiol., 41, 578
  15. 10.1097/SHK.0b013e3182a185ab · DOI · Paper page
  16. Miyazaki D., 2016, Elevation of serum heat‐shock protein levels in amyotrophic lateral sclerosis. Neurol, Sci., 37, 1277
  17. Lindberg I., 2015, Chaperones in neurodegeneration. J, Neurosci., 35, 13853, 10.1523/JNEUROSCI.2600-15.2015 · DOI · Paper page
  18. 10.3389/fimmu.2012.00074 · DOI
  19. 10.1073/pnas.1117799109 · DOI · Paper page
  20. 10.1096/fj.10-164624 · DOI · Paper page
  21. Binder R. J., 2014, Functions of heat shock proteins in pathways of the innate and adaptive immune system. J, Immunol., 193, 5765
  22. 10.3389/fimmu.2016.00159 · DOI · Paper page
  23. 10.1096/fj.15-275131 · DOI
  24. Labrador‐Garrido A., 2014, Chaperoned amyloid proteins for immune manipulation: α‐synuclein/Hsp70 shifts immunity toward a modulatory phenotype. Immun. Inflamm, Dis., 2, 226
  25. 10.1002/glia.21109 · DOI
  26. Mayo L., 2008, Dual role of CD38 in microglial activation and activation‐induced cell death. J, Immunol., 181, 92
  27. 10.1016/j.neuroscience.2008.04.078 · DOI
  28. 10.1371/journal.pone.0086720 · DOI · Paper page
  29. 10.1038/emboj.2009.298 · DOI
  30. Martínez‐Fábregas J., 2014, Structural and functional analysis of novel human cytochrome C targets in apoptosis. Mol. Cell, Proteomics, 13, 1439
  31. Cascella R., 2016, Quantification of the relative contributions of loss‐of‐function and gain‐of‐function mechanisms in TAR DNA‐binding protein 43 (TDP‐43) proteinopathies. J. Biol, Chem., 291, 19437
  32. Igaz L. M., 2008, Enrichment of C‐terminal fragments in TAR DNA‐binding protein‐43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J, Pathol., 173, 182
  33. 10.1002/glia.22891 · DOI · Paper page
  34. 10.1038/cddis.2014.514 · DOI
  35. Garcia‐Faroldi G., 2013, Active caspase‐3 is stored within secretory compartments of viable mast cells. J, Immunol., 191, 1445
  36. 10.1046/j.1365-2443.1999.00261.x · DOI
  37. Fu J. Z., 2012, Regulations and functions of ICK/MAK/MOK–a novel MAPK‐related kinase family linked to human diseases. In Protein Kinases, 229
  38. 10.1111/jnc.13625 · DOI · Paper page
  39. 10.1186/1742-2094-7-9 · DOI · Paper page
  40. Omoto Y., 2006, Human mast cell chymase cleaves pro‐IL‐18 and generates a novel and biologically active IL‐18 fragment. J, Immunol., 177, 8315
  41. Akita K., 1997, Involvement of caspase‐1 and caspase‐3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells. J. Biol, Chem., 272, 26595
  42. 10.1371/journal.pone.0079160 · DOI · Paper page
  43. 10.1093/brain/aww028 · DOI · Paper page
  44. Udan‐Johns M., 2014, Prion‐like nuclear aggregation of TDP‐43 during heat shock is regulated by HSP40/70 chaperones. Hum. Mol, Genet., 23, 157
  45. 10.1038/ncomms3757 · DOI
  46. Jain M. R., 2008, Amyotrophic lateral sclerosis: protein chaperone dysfunction revealed by proteomic studies of animal models. Proteomics Clin, Appl., 2, 670
  47. Bruinsma I. B., 2011, Small heat shock proteins induce a cerebral inflammatory reaction. J, Neurosci., 31, 11992, 10.1523/JNEUROSCI.0945-11.2011 · DOI · Paper page
  48. 10.1007/s12192-012-0356-0 · DOI
  49. 10.3389/fimmu.2012.00095 · DOI · Paper page
  50. 10.1371/journal.pcbi.1003471 · DOI
  51. 10.1007/s12192-016-0676-6 · DOI · Paper page
  52. 10.15252/embj.201591407 · DOI
  53. 10.1038/cdd.2011.107 · DOI
  54. Eichmuller S., 2002, mRNA expression of tumor‐associated antigens inmelanoma tissues and cell lines. Exp, Dermatol., 11, 292

Cited by

Metadata

Authors
Leal‐Lasarte, M. M., Franco, J. M., Labrador‐Garrido, A., Pozo, D., & Roodveldt, C.
Venue
The FASEB Journal
Publisher
Wiley
Published
2017-03-23
Volume
31
Issue
7
Pages
2797-2816
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2603088576
Cited by
53
References
14
FWCI
2.93
Type
journal article
Language
en
Open access
closed
Funders
  • European Regional Development Fund (CP10/00527, SAF-2012-39720, RTC-2015-3309-1, PS09-2252-ISCIII, P11-CTS8161)
  • Instituto de Salud Carlos III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.